Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Google Inc (GOOG) vs Revvity Inc (RVTY) Price & Performance

Google IncTrade
Revvity IncTrade

Price performance (Past 24H)

Key statistics

Google Inc vs Revvity Inc — how do they compare? Google Inc trades at $349.01 (market cap $4.24T), while Revvity Inc trades at $154.82 (market cap $16.98B). The key difference: Google Inc is far larger — about 249.7× Revvity Inc's market cap, and Google Inc pays the higher dividend (0.26%). Which is the better fit depends on your goals — on Pluang, investors hold Google Inc for 137 Days and Revvity Inc for 12 Days on average.

GOOGRVTY
Market Cap
$4.24T$16.98B
Volume
13,937,9021,456,900
Sector
MediaHealth
52-Week High
$399.06$157.36
52-Week Low
$237.49$82.26
Typical Hold Time
137 Days12 Days
Enterprise Value
$4.13T$19.30B
Dividend Yield
0.26%0.18%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Google Inc

Alphabet (GOOG) trades at $350.02, up 0.76% with strong technical momentum and bullish moving average signals. The company demonstrates exceptional financial performance with 32.8% net margins and consistent earnings beats, though significant capital expenditures have led to negative free cash flow concerns. Analyst consensus remains overwhelmingly positive with 87% buy ratings and a $435.24 price target, representing 24% upside potential from current levels.

The outlook remains favorable given Alphabet's dominant market position and AI leadership, though investors face risks from escalating capital spending, regulatory scrutiny, and multiple class-action lawsuits. The stock's current valuation at 17.3x P/E appears reasonable relative to growth prospects, supported by robust cash flow generation and expanding cloud revenue streams.

Revvity Inc

Revvity (RVTY) trades at $154.33, up 0.48% on the day and near its 52-week high of $158.28. The stock exhibits a bullish technical trend with strong moving average signals, while recent earnings beats and positive analyst upgrades reflect solid fundamentals. Key developments include the launch of a new Type 1 diabetes screening kit in Europe and the acquisition of Human Cell Design to bolster metabolic disease research, signaling growth in diagnostics and life sciences.

The outlook remains positive given consistent earnings outperformance and strategic expansions, though rich valuation multiples pose a risk if growth moderates. Investors face near-term headwinds from margin pressures in China and elevated P/E ratios, but institutional accumulation and a lack of sell ratings support a constructive bias for long-term holders.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GOOG
17% Buy83% Sell
Avg holding period · 137 Days
RVTY
0% Buy100% Sell
Avg holding period · 12 Days

Top news

Latest headlines on both assets

About Google Inc

Alphabet Inc. operates as a holding company. The Company, through its subsidiaries, provides web-based search, advertisements, maps, software applications, mobile operating systems, consumer content, enterprise solutions, commerce, and hardware products.

Read more on GOOG →

About Revvity Inc

Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.

Read more on RVTY →